Back to Search

LXRX

Lexicon Pharmaceuticals, Inc.
Data: 2026-02-02
$1.235
Price
6.47%
Change
$1.83
52W High
$0.2836
52W Low
Buy/Sell Forecast Trendline Why Moving Charts Options

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Quick Stats
Feb 02, 2026

53.8

AI Score

HOLD

0.42

Volume Ratio

Mar 05, 2026

Next Earnings

14

+ve Days (30d)

13

-ve Days (30d)

LXRX Stock Summary

Last updated

LXRX is currently trading at $1.235, positioned above its 200-day moving average of $1.12, indicating a long-term uptrend. The stock has a 52-week range of $0.2836 to $1.83.

Technical Analysis: The 50-day moving average stands at $1.32, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads , suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is , which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates LXRX at 53.8/100 with a HOLD recommendation.

LXRX Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

LXRX Price vs Max Options Open Interest
LXRX Max Change In Options Open Interest

LXRX Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

LXRX Daily Out of Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

LXRX Daily In the Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

LXRX Most Active Options by Volume(near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Lexicon Pharmaceuticals, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

LXRX Moving Averages Analysis

Lexicon Pharmaceuticals, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 02, 2026

LXRX (Lexicon Pharmaceuticals, Inc.) Simple Moving Averages

Moving Averages are last updated Feb 02, 2026

Days MA
10 1.49
20 1.35
30 1.3
50 1.32
100 1.34
200 1.12

LXRX Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 421.6 million
Earnings/Share ($) -0.19
Net Proft Margin (%) -0.9677
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.1669
EPS Estimate Next Year ($) -0.2466
WallStreet Target Price ($) 2.92
Most Recent Quarter